Actively Recruiting
Randomized Study to Compare Immune Response and Safety of an mRNA Seasonal Flu Vaccine Versus Comparator Vaccines in Adults 18 to 64 Years
Led by GlaxoSmithKline · Updated on 2026-10-09
3000
Participants Needed
12
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying an investigational seasonal influenza vaccine based on messenger RNA mRNA in adults aged 18 to 64 years. This Phase 3 clinical trial aims to assess the immune response the vaccine triggers against influenza and to monitor any medical problems participants may experience after vaccination. The study also compares immune responses from adults 18 to 64 years old with those from adults 65 and older in a separate study. Participants will receive one injection into the upper arm muscle on Day 1. The trial includes multiple groups receiving either the investigational mRNA vaccine or one of two comparator vaccines. Those aged 60 to 64 years are included in a specific cohort receiving either the mRNA vaccine or comparator 2. The study uses a randomized, observer-blind, parallel design to compare these vaccines. During the study, participants will be followed for approximately six months. Researchers will collect blood samples before and after vaccination to measure antibody levels and immune responses. They will also monitor for adverse events, including local and systemic reactions, other medical events, serious events, and laboratory abnormalities. The main outcomes are antibody titers and seroconversion rates measured 29 days after vaccination, with safety assessed throughout the 6-month follow-up.
CONDITIONS
Brief Title
A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
Research Team
U
US GSK Clinical Trials Call Center
E
EU GSK Clinical Trials Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here